US equities
|
SPCX
$168.68
▲+6.11%
NVDA
$237.94
▲+1.70%
MU
$1,065.50
▼-0.87%
TSLA
$379.86
▲+2.50%
MSFT
$525.20
▲+1.48%
SNDK
$1,715.45
▼-0.26%
INTC
$117.11
▼-1.86%
META
$744.31
▲+2.23%
SPCX
$168.68
▲+6.11%
NVDA
$237.94
▲+1.70%
MU
$1,065.50
▼-0.87%
TSLA
$379.86
▲+2.50%
MSFT
$525.20
▲+1.48%
SNDK
$1,715.45
▼-0.26%
INTC
$117.11
▼-1.86%
META
$744.31
▲+2.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Aytu BioPharma, Inc. - Common Stock
(NQ:
AYTU
)
2.100
+0.030 (+1.45%)
Delayed Quote
Updated: 1:37 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aytu BioPharma, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
↗
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
↗
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
Aytu BioPharma to Report Third Quarter Fiscal 2021 Results on May 17, 2021
May 10, 2021
ENGLEWOOD, CO / ACCESSWIRE / May 10, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products,...
From
Aytu BioPharma, Inc.
Via
AccessWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
April 21, 2021
Gainers Alterity Therapeutics (NASDAQ:ATHE) stock rose 23.16% to $1.54 during Wednesday's pre-market session. The company's market cap stands at $53.4 million....
Via
Benzinga
Aytu BioPharma Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline from Rumpus Therapeutics
April 12, 2021
Aytu gains global license to pivotal study-ready protein kinase C β isoform (PKCβ) inhibitor, AR101 (enzastaurin) in rare disease indications Program initially targeting vascular Ehlers-Danlos Syndrome...
From
Aytu BioPharma, Inc.
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
↗
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
↗
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
